Weiguo Dong
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
-
- Nigella sativa pharmacological applications
Papers in
-
- Gut microbiota and health 7
- Wnt/β-catenin signaling in development and cancer 7
- Genomics, phytochemicals, and oxidative stress 6
- Oncology 27
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Jixiang Zhang (60 shared papers)Dandan Wu (11 shared papers)Vikash Vikash (3 shared papers)Qing Ye (2 shared papers)Xiaoli Wang (6 shared papers)Yulan Liu (1 shared paper)Na Zhan (17 shared papers)Yu Xu (8 shared papers)
- Journals
- PLoS ONE (8 papers)Digestive Diseases and Sciences (8 papers)World Journal of Gastroenterology (7 papers)Journal of Inflammation Research (7 papers)Medical Oncology (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weiguo Dong
191 papers receiving 6.3k citations
Weiguo Dong's Hit Papers
Peers
Comparison fields: 5 of 172
- Toxicology 200
- Complementary and alternative medicine 325
- Neurology 525
- Cancer Research 501
- Infectious Diseases 539
Countries citing papers authored by Weiguo Dong
This map shows the geographic impact of Weiguo Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Dong more than expected).
Fields of papers citing papers by Weiguo Dong
This network shows the impact of papers produced by Weiguo Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Dong. The network helps show where Weiguo Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiguo Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ROS and ROS‐Mediated Cellular Signaling Hit paper breakdown → | 2016 | 1563 |
| 2 | Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study Hit paper breakdown → | 2020 | 479 |
| 3 | 2020 | 467 | |
| 4 | 2020 | 164 | |
| 5 | 2016 | 152 | |
| 6 | 2019 | 151 | |
| 7 | 2011 | 105 | |
| 8 | 2015 | 90 | |
| 9 | 2019 | 84 | |
| 10 | 2016 | 84 | |
| 11 | 2021 | 82 | |
| 12 | 2015 | 74 | |
| 13 | 2017 | 64 | |
| 14 | 2015 | 63 | |
| 15 | 2022 | 58 | |
| 16 | 2018 | 56 | |
| 17 | 2015 | 55 | |
| 18 | 2020 | 52 | |
| 19 | 2018 | 49 | |
| 20 | 2014 | 47 |
About Weiguo Dong
Weiguo Dong is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 194 papers that have together received 6.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (21 papers), Helicobacter pylori-related gastroenterology studies (8 papers), Gut microbiota and health (7 papers), Wnt/β-catenin signaling in development and cancer (7 papers), Gastric Cancer Management and Outcomes (6 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Toxicology (200 citations), Complementary and alternative medicine (325 citations), Neurology (525 citations), Cancer Research (501 citations) and Infectious Diseases (539 citations). Weiguo Dong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jixiang Zhang, Dandan Wu, Vikash Vikash, Qing Ye, Xiaoli Wang, Yulan Liu, Na Zhan, Yu Xu, Xufeng Guo and Shan Tian. Their work appears in journals such as PLoS ONE, Digestive Diseases and Sciences, World Journal of Gastroenterology, Journal of Inflammation Research and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.